ZA917597B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA917597B
ZA917597B ZA917597A ZA917597A ZA917597B ZA 917597 B ZA917597 B ZA 917597B ZA 917597 A ZA917597 A ZA 917597A ZA 917597 A ZA917597 A ZA 917597A ZA 917597 B ZA917597 B ZA 917597B
Authority
ZA
South Africa
Prior art keywords
pct
agent
sulphate
sec
provides
Prior art date
Application number
ZA917597A
Other languages
English (en)
Inventor
Professor Donald Selwyn Davies
Donald Selwyn Davies Professor
Original Assignee
Ml Lab Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ml Lab Plc filed Critical Ml Lab Plc
Publication of ZA917597B publication Critical patent/ZA917597B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/02—Esters
    • C08B31/06—Esters of inorganic acids
    • C08B31/063—Starch sulfates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA917597A 1990-09-25 1991-09-24 Pharmaceutical compositions ZA917597B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909020861A GB9020861D0 (en) 1990-09-25 1990-09-25 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA917597B true ZA917597B (en) 1992-05-27

Family

ID=10682722

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917597A ZA917597B (en) 1990-09-25 1991-09-24 Pharmaceutical compositions

Country Status (15)

Country Link
US (2) US5439892A (de)
EP (1) EP0550532B1 (de)
JP (1) JP3281373B2 (de)
AT (1) ATE165005T1 (de)
AU (1) AU649731B2 (de)
CA (1) CA2092094C (de)
DE (1) DE69129272T2 (de)
DK (1) DK0550532T3 (de)
ES (1) ES2113888T3 (de)
GB (1) GB9020861D0 (de)
IE (1) IE913340A1 (de)
NZ (1) NZ239908A (de)
PT (1) PT99057B (de)
WO (1) WO1992004904A1 (de)
ZA (1) ZA917597B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9625193D0 (en) * 1996-12-04 1997-01-22 Ml Lab Plc Treatment of highly vascular tumours
ATE317703T1 (de) 1997-06-12 2006-03-15 Innovata Plc Polymer-wirkstoff-konjugate zur behandlung von krebs
US6077503A (en) * 1997-07-30 2000-06-20 Amway Corporation Skin whitener composition containing mercaptodextran
US20050209189A1 (en) * 2001-03-06 2005-09-22 Roger Hershline Antiviral composition
US6821958B1 (en) 2001-03-06 2004-11-23 Roger K. Hershline Antiviral composition
US20050080045A1 (en) * 2001-12-24 2005-04-14 Alan Chapman Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
US20040009953A1 (en) * 2002-01-10 2004-01-15 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
US20030181416A1 (en) * 2002-01-10 2003-09-25 Comper Wayne D. Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
WO2004064850A1 (en) * 2003-01-23 2004-08-05 Ml Laboratories Plc Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
US7285582B2 (en) * 2004-12-30 2007-10-23 Conocophillips Company Modified latex drag reducer and processes therefor and therewith
US20070225191A1 (en) * 2006-03-27 2007-09-27 The Procter & Gamble Company Methods for modifying bioplymers in ionic liquids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2967178A (en) * 1957-12-06 1961-01-03 Corn Products Co Method of producing gelling starch of high clarity
US3017407A (en) * 1958-08-18 1962-01-16 Riker Laboratories Inc Process for producing polysulfuric acid esters of polysaccharides
US3070595A (en) * 1960-10-28 1962-12-25 Riker Laboratories Inc Process for producing polysulfuric acid esters of polysaccharides
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
EP0240098A3 (de) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo und Polysaccharide zur Behandlung von Krankheiten verursacht durch Retroviren
SE453394B (sv) * 1986-07-07 1988-02-01 Pharmacia Ab Forfarande for framstellning av sulfaterade polysackarider genom anvendning av ett reducerande medel for sulfateringsreaktionen
WO1989003684A1 (en) * 1987-10-30 1989-05-05 Chugai Seiyaku Kabushiki Kaisha Anti-hiv agent
GB9001687D0 (en) * 1990-01-25 1990-03-28 Ml Lab Plc Treatment of poisoning and composition for use therein
US5221669A (en) * 1991-04-19 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions containing α-cyclodextrin sulfates alone and in combination with other known antiviral agents and glucocorticoids and methods of treating viral infections

Also Published As

Publication number Publication date
US5439892A (en) 1995-08-08
PT99057B (pt) 1999-02-26
ATE165005T1 (de) 1998-05-15
CA2092094C (en) 2004-08-10
WO1992004904A1 (en) 1992-04-02
DE69129272D1 (de) 1998-05-20
JP3281373B2 (ja) 2002-05-13
US6015799A (en) 2000-01-18
NZ239908A (en) 1993-03-26
AU8614591A (en) 1992-04-15
EP0550532A1 (de) 1993-07-14
IE913340A1 (en) 1992-02-25
GB9020861D0 (en) 1990-11-07
CA2092094A1 (en) 1992-03-26
ES2113888T3 (es) 1998-05-16
PT99057A (pt) 1992-08-31
AU649731B2 (en) 1994-06-02
JPH06503305A (ja) 1994-04-14
DE69129272T2 (de) 1998-11-12
EP0550532B1 (de) 1998-04-15
DK0550532T3 (da) 1999-03-08

Similar Documents

Publication Publication Date Title
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
TW261513B (de)
ZA917597B (en) Pharmaceutical compositions
GB2269589B (en) 3-Hydroxy-pyridin-4-ones and their use in pharmaceutical compositions
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
IL112999A0 (en) Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them
HU9201267D0 (en) Method for producing pharmaceutical preparatives containing gfi
DE69109293D1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
ATE169021T1 (de) Cephalostatin-analoga und ihre verwendung als antitumormittel
ATE161186T1 (de) Verwendung von apotransferrin, welches zink- oder kupferionen angelagert hat, zur bekämpfung der toxischen wirkung des endotoxins
MX9504565A (es) Composicion farmaceutica que contiene timoctonan y azt.